The complete chloroplast genome sequence of Hemerocallis fulva

Yan Zheng; Jingling Li; Haimei Chen; Linfang Huang

doi:10.1080/23802359.2020.1829126

The complete chloroplast genome sequence of Hemerocallis fulva

Mitochondrial DNA B Resour. 2020 Oct 9;5(3):3543-3544. doi: 10.1080/23802359.2020.1829126.

Authors

Yan Zheng^{1

2}, Jingling Li^{1

3}, Haimei Chen¹, Linfang Huang¹

Affiliations

¹ Key Research Laboratory of Traditional Chinese Medicine Resources Protection, Administration of Traditional Chinese Medicine, National administration of Traditional Chinese Medicine, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
² Jiangxi University of Traditional Chinese Medicine, Nanchang, Jiangxi.
³ Southwest University, Chongqing, China.

Abstract

Hemerocallis fulva L. is a traditional Chinese medicine. The flowers of H. fulva are used in ethnic medicine to treat various diseases, including certain central nervous system diseases. In this study, we characterized the complete chloroplast genome of H. fulva. It is 156,059 bp in length and encodes 87 protein-coding genes, 38 transfer RNA (tRNA) genes, and 8 ribosomal RNA (rRNA) genes. The phylogenomic analysis showed that the H. fulva and species of Anemarrhena asphodeloides Bunge, Liriope muscari, and Liriope spicata were clustered together. This chloroplast genome sequencing offers genetic background for conservation and phylogenetic studies.

Keywords: Chloroplast genome; Hemerocallis fulva; phylogenetic analysis.

Grants and funding

This work was supported by Beijing Natural Scientific Foundation [No. 7202135]. National Natural Science Foundation of China [U1812403-1-1 and 82073960], National Science & Technology Fundamental Resources Investigation Program of China [2018FY100701], the Open Research Fund of Chengdu University of Traditional Chinese Medicine Key Laboratory of Systematic Research of Distinctive Chinese Medicine Resources in Southwest China [003109034001], Chinese Academy of Medical Sciences, Innovation Funds for Medical Sciences (CIFMS) [2017-I2M-1-013].